MedTrace Logo

Serum Talin-1 and Cripto-1 in Colorectal Cancer

NCT07414082 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-02-17

No results posted yet for this study

Summary

The goals of this study are

* To evaluate the clinical utility of Talin-1 and Cripto-1 measurement in colorectal cancer patients in comparison with healthy controls.
* To Compare the diagnostic significance of serum Talin-1 and Cripto-1 with traditional serum biomarker CEA

Conditions

  • Colo-rectal Cancer

Interventions

DIAGNOSTIC_TEST

Serum level of Human Talin-1

To evaluate the clinical utility of Talin-1 measurement in colorectal cancer patients in comparison with healthy controls.

DIAGNOSTIC_TEST

Serum level of Human Cripto-1

To evaluate the clinical utility of Cripto-1 measurement in colorectal cancer patients in comparison with healthy controls.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-30
Primary Completion
2028-12-31
Completion
2029-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07414082 on ClinicalTrials.gov